Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study

INTRODUCTION: β-Blockers are a heterogenous class of drugs that are no longer recommended for initial antihypertension monotherapy due to unfavorable long-term cardiovascular events observed with non-vasodilatory β-blockers. However, the comparative cardiovascular event risk between the vasodilatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Basile, Jan, Egan, Brent, Punzi, Henry, Ali, Sanjida, Li, Qian, Patel, Mehul, Neutel, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251822/
https://www.ncbi.nlm.nih.gov/pubmed/30191469
http://dx.doi.org/10.1007/s40119-018-0117-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251822/
https://www.ncbi.nlm.nih.gov/pubmed/30191469
http://dx.doi.org/10.1007/s40119-018-0117-y

Ejemplares similares